200 related articles for article (PubMed ID: 15483195)
1. In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.
Giraud C; Tran A; Rey E; Vincent J; Tréluyer JM; Pons G
Drug Metab Dispos; 2004 Nov; 32(11):1279-86. PubMed ID: 15483195
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.
Giraud C; Treluyer JM; Rey E; Chiron C; Vincent J; Pons G; Tran A
Drug Metab Dispos; 2006 Apr; 34(4):608-11. PubMed ID: 16415114
[TBL] [Abstract][Full Text] [Related]
3. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
[TBL] [Abstract][Full Text] [Related]
4. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
[TBL] [Abstract][Full Text] [Related]
5. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
Ramírez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ
Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
7. O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes.
Liu ZQ; Zhu B; Tan YF; Tan ZR; Wang LS; Huang SL; Shu Y; Zhou HH
J Pharmacol Exp Ther; 2002 Jan; 300(1):105-11. PubMed ID: 11752104
[TBL] [Abstract][Full Text] [Related]
8. Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19.
Hirani VN; Raucy JL; Lasker JM
Drug Metab Dispos; 2004 Dec; 32(12):1462-7. PubMed ID: 15448116
[TBL] [Abstract][Full Text] [Related]
9. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation.
Stresser DM; Kupfer D
Drug Metab Dispos; 1998 Sep; 26(9):868-74. PubMed ID: 9733665
[TBL] [Abstract][Full Text] [Related]
10. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
Casabar RC; Wallace AD; Hodgson E; Rose RL
Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes.
Kim KA; Kim MJ; Park JY; Shon JH; Yoon YR; Lee SS; Liu KH; Chun JH; Hyun MH; Shin JG
Drug Metab Dispos; 2003 Oct; 31(10):1227-34. PubMed ID: 12975331
[TBL] [Abstract][Full Text] [Related]
13. A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam.
Kosaki K; Tamura K; Sato R; Samejima H; Tanigawara Y; Takahashi T
Brain Dev; 2004 Dec; 26(8):530-4. PubMed ID: 15533655
[TBL] [Abstract][Full Text] [Related]
14. Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate.
Naritomi Y; Terashita S; Kagayama A
Xenobiotica; 2004 May; 34(5):415-27. PubMed ID: 15370958
[TBL] [Abstract][Full Text] [Related]
15. Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.
Volotinen M; Turpeinen M; Tolonen A; Uusitalo J; Mäenpää J; Pelkonen O
Drug Metab Dispos; 2007 Jul; 35(7):1135-41. PubMed ID: 17431033
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes.
Abelö A; Andersson TB; Antonsson M; Naudot AK; Skånberg I; Weidolf L
Drug Metab Dispos; 2000 Aug; 28(8):966-72. PubMed ID: 10901708
[TBL] [Abstract][Full Text] [Related]
17. Enantiomer/enantiomer interactions between the S- and R- isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4.
Li XQ; Weidolf L; Simonsson R; Andersson TB
J Pharmacol Exp Ther; 2005 Nov; 315(2):777-87. PubMed ID: 16093273
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
Gerber JG; Rhodes RJ; Gal J
Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
[TBL] [Abstract][Full Text] [Related]
19. Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam.
Contin M; Sangiorgi S; Riva R; Parmeggiani A; Albani F; Baruzzi A
Ther Drug Monit; 2002 Dec; 24(6):737-41. PubMed ID: 12451290
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 3-O-methylfluorescein as a selective fluorometric substrate for CYP2C19 in human liver microsomes.
Sudsakorn S; Skell J; Williams DA; O'Shea TJ; Liu H
Drug Metab Dispos; 2007 Jun; 35(6):841-7. PubMed ID: 17332142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
